Gustavo Gers-Huber

645 total citations
7 papers, 474 citations indexed

About

Gustavo Gers-Huber is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Gustavo Gers-Huber has authored 7 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 5 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Gustavo Gers-Huber's work include HIV Research and Treatment (5 papers), Immune Cell Function and Interaction (3 papers) and interferon and immune responses (2 papers). Gustavo Gers-Huber is often cited by papers focused on HIV Research and Treatment (5 papers), Immune Cell Function and Interaction (3 papers) and interferon and immune responses (2 papers). Gustavo Gers-Huber collaborates with scholars based in Switzerland, United States and India. Gustavo Gers-Huber's co-authors include Bastien Mangeat, Martin Lehmann, Vincent Piguet, Jeremy Luban, Madeleine Zufferey, Annette Audigé, Roberto F. Speck, Mary-Aude Rochat, Inderdeep Kaur and Yves Thomas and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Gustavo Gers-Huber

7 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustavo Gers-Huber Switzerland 7 309 204 166 136 115 7 474
Serena Ziglio Italy 6 394 1.3× 189 0.9× 160 1.0× 201 1.5× 143 1.2× 8 525
Rahel Byland Switzerland 8 303 1.0× 210 1.0× 124 0.7× 133 1.0× 120 1.0× 8 489
William J. Neidermyer United States 8 305 1.0× 341 1.7× 209 1.3× 195 1.4× 134 1.2× 10 603
Julie Binette Canada 6 372 1.2× 181 0.9× 152 0.9× 120 0.9× 160 1.4× 7 503
J F Rowell United States 7 301 1.0× 212 1.0× 145 0.9× 173 1.3× 110 1.0× 8 498
Josephine Romano United States 10 466 1.5× 269 1.3× 99 0.6× 221 1.6× 109 0.9× 12 526
Suzanne Pickering United Kingdom 12 381 1.2× 346 1.7× 187 1.1× 294 2.2× 157 1.4× 18 738
Vanessa B. Soros United States 9 394 1.3× 176 0.9× 201 1.2× 196 1.4× 300 2.6× 13 660
Christian Krapp Denmark 9 180 0.6× 318 1.6× 146 0.9× 128 0.9× 194 1.7× 11 520

Countries citing papers authored by Gustavo Gers-Huber

Since Specialization
Citations

This map shows the geographic impact of Gustavo Gers-Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo Gers-Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo Gers-Huber more than expected).

Fields of papers citing papers by Gustavo Gers-Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo Gers-Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo Gers-Huber. The network helps show where Gustavo Gers-Huber may publish in the future.

Co-authorship network of co-authors of Gustavo Gers-Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo Gers-Huber. A scholar is included among the top collaborators of Gustavo Gers-Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo Gers-Huber. Gustavo Gers-Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hernandez, Matthew M., Anitha D. Jayaprakash, Gustavo Gers-Huber, et al.. (2019). Impact of Suboptimal APOBEC3G Neutralization on the Emergence of HIV Drug Resistance in Humanized Mice. Journal of Virology. 94(5). 13 indexed citations
2.
Audigé, Annette, Mary-Aude Rochat, Duo Li, et al.. (2017). Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells. BMC Immunology. 18(1). 28–28. 42 indexed citations
3.
Myburgh, Renier, Sandra Ivic, Michael S. Pepper, et al.. (2015). Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice. Journal of Virology. 89(13). 6761–6772. 31 indexed citations
4.
Mangeat, Bastien, Martin Lehmann, Gustavo Gers-Huber, et al.. (2012). Influenza Virus Partially Counteracts Restriction Imposed by Tetherin/BST-2. Journal of Biological Chemistry. 287(26). 22015–22029. 65 indexed citations
5.
Gers-Huber, Gustavo, et al.. (2012). Modelling HIV infection and therapies in humanised mice. Swiss Medical Weekly. 142(2728). w13618–w13618. 23 indexed citations
6.
Sutmuller, Roger P.M., Gustavo Gers-Huber, Annette Audigé, et al.. (2012). Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting Anti-Retroviral Drugs for Treating HIV-1. PLoS ONE. 7(6). e38853–e38853. 64 indexed citations
7.
Mangeat, Bastien, Gustavo Gers-Huber, Martin Lehmann, et al.. (2009). HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation. PLoS Pathogens. 5(9). e1000574–e1000574. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026